Experimental browser for the Atmosphere
An ex-FDA employee who has tested ChatGPT as a clinical tool says the propensity of AI models to fabricate convincing information raises questions about how reliable such a chatbot might be. “Who knows how robust the platform will be for these reviewers’ tasks,” the ex-staffer says.
May 7, 2025, 8:02 PM
{ "uri": "at://did:plc:inz4fkbbp7ms3ixufw6xuvdi/app.bsky.feed.post/3lom6vzm6f227", "cid": "bafyreihnoevag4bctz4bmxh62kbpvc3zrmulhvomhcdi4pdfgpfnnubnm4", "value": { "text": "An ex-FDA employee who has tested ChatGPT as a clinical tool says the propensity of AI models to fabricate convincing information raises questions about how reliable such a chatbot might be. “Who knows how robust the platform will be for these reviewers’ tasks,” the ex-staffer says.", "$type": "app.bsky.feed.post", "embed": { "$type": "app.bsky.embed.external", "external": { "uri": "https://www.wired.com/story/openai-fda-doge-ai-drug-evaluation/", "thumb": { "$type": "blob", "ref": { "$link": "bafkreidculcut3vonlefd3yhedsigjr37onhcr6xrb5osc5zx3s44ovdti" }, "mimeType": "image/jpeg", "size": 470199 }, "title": "OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation", "description": "High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT." } }, "langs": [ "en" ], "reply": { "root": { "cid": "bafyreigyd7ea3hel3rzblt7xqdglcw5ppowyilhg74gccr435pxpc73lna", "uri": "at://did:plc:inz4fkbbp7ms3ixufw6xuvdi/app.bsky.feed.post/3lom6tbalxk27" }, "parent": { "cid": "bafyreigyd7ea3hel3rzblt7xqdglcw5ppowyilhg74gccr435pxpc73lna", "uri": "at://did:plc:inz4fkbbp7ms3ixufw6xuvdi/app.bsky.feed.post/3lom6tbalxk27" } }, "createdAt": "2025-05-07T20:02:54.236Z" } }